Oxford BioTherapeutics Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody™ Platform for Five Bispecific Antibody Programs for up to $450 Million Life Science
WuXi Biologics Announced Exclusive Discovery Research with Brii Biosciences for Novel Bispecific Antibody Immunotherapeutics Life Science
Brii Biosciences Builds Innovative Pipeline, Forges Public-Private Partnerships to Bring Novel Medicines to Chinese Patients Life Science
WuXi Biologics Commenced Construction of the Largest Biomanufacturing Facility Using Single-Use Bioreactors in Ireland Life Science
Innovent Receives an Approval from the US FDA to Initiate Clinical Trials for its Anti-OX40 Monoclonal Antibody IBI101 Life Science
China News Weekly 89 – Tencent Music presses play on $1.2 billion U.S. IPO Financial Service, Life Science, Technology
Origin House to Acquire Cub City – Craft Cannabis Production Facility and Operational Team – to Expand Brand Accelerator Program Cannabis, Life Science
HitGen Enters into DNA-Encoded Library Based Drug Discovery Research Collaboration with Genentech Life Science
